Feiyang Xing

机构：Tongji University, Intelligent Systems Research (United States), Shanghai Skin Disease Hospital · ORCID：0000-0002-7129-1947

发表论文 9 篇 · 总被引 231 次 · h-index 6

代表论文

• The tumor therapy landscape of synthetic lethality (2021 · Nature Communications · 被引 74)
• Single-cell omics: experimental workflow, data analyses and applications (2024 · Science China Life Sciences · 被引 73)
• Personalized tumor combination therapy optimization using the single-cell transcriptome (2023 · Genome Medicine · 被引 31)
• O-Linked N-acetylglucosamine transferase 1 regulates global histone H4 acetylation via stabilization of the nonspecific lethal protein NSL3 (2017 · Journal of Biological Chemistry · 被引 24)
• The chromatin remodeling protein INO80 contributes to the removal of H2A.Z at the p53‐binding site of the p21 gene in response to doxorubicin (2018 · FEBS Journal · 被引 16)
• Molecular bases of morphologically diffused tumors across multiple cancer types (2022 · National Science Review · 被引 6)